Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program
Tuesday, May 5, 2020 - First participants dosed at NYU Grossman School of Medicine and University of Maryland School of ...
Read moreDetails
